OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF‐κB as the mediator of metformin's effect on ageing and ageing‐related diseases
Gönül Kanıgür Sultuybek, Tuğba Soydaş, Güven Yenmiş
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 46, Iss. 5, pp. 413-422
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
Paul D. Robbins, Diana Jurk, Sundeep Khosla, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 779-803
Open Access | Times Cited: 218

Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
Sheng Chen, Donghao Gan, Sixiong Lin, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2722-2740
Open Access | Times Cited: 115

Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Guadalupe Elizabeth Jiménez-Gutiérrez, Laura E. Martínez-Gómez, Carlos Martínez-Armenta, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2359-2359
Open Access | Times Cited: 104

Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
Hu Li, Huiqin Li, Meiting Zi, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 93

Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4083-4083
Open Access | Times Cited: 17

Anticancer mechanisms of metformin: A review of the current evidence
Bin Zhao, Jie Luo, Tongyao Yu, et al.
Life Sciences (2020) Vol. 254, pp. 117717-117717
Closed Access | Times Cited: 100

Age-related mitochondrial dysfunction as a key factor in COVID-19 disease
Daniel J.M. Fernández‐Ayala, Plácido Navas, Guillermo López‐Lluch
Experimental Gerontology (2020) Vol. 142, pp. 111147-111147
Open Access | Times Cited: 97

Role of Cellular Senescence in Type II Diabetes
Akilavalli Narasimhan, Rafael R. Flores, Paul D. Robbins, et al.
Endocrinology (2021) Vol. 162, Iss. 10
Open Access | Times Cited: 84

NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1775-1789
Open Access | Times Cited: 34

The crosstalk between Nrf2 and NF-κB pathways in coronary artery disease: Can it be regulated by SIRT6?
Eman Casper
Life Sciences (2023) Vol. 330, pp. 122007-122007
Closed Access | Times Cited: 34

Oxidative stress and type 2 diabetes: a review of lactic acid bacteria as potential prophylactic and therapeutic interventions
Siheng Ren, Juan Wang, Yuxi Wang, et al.
Food Science and Biotechnology (2025)
Closed Access | Times Cited: 1

Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
Sebastian N. Knoppert, Floris A. Valentijn, Tri Q. Nguyen, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 75

Current pharmacotherapies for sarcopenia
Justin P. Hardee, Gordon S. Lynch
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 13, pp. 1645-1657
Closed Access | Times Cited: 72

Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke
Sejal Sharma, Saeideh Nozohouri, Bhuvaneshwar Vaidya, et al.
Life Sciences (2021) Vol. 274, pp. 119343-119343
Open Access | Times Cited: 49

Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
Hyoungnae Kim, Mi Ra Yu, Haekyung Lee, et al.
Aging Cell (2021) Vol. 20, Iss. 2
Open Access | Times Cited: 48

Advances in research on pharmacotherapy of sarcopenia
Yang Feike, Zhijie Liu, Wei Chen
Aging Medicine (2021) Vol. 4, Iss. 3, pp. 221-233
Open Access | Times Cited: 47

Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells
Ruolan You, Bin Wang, Ping Chen, et al.
Cancer Letters (2022) Vol. 532, pp. 215582-215582
Open Access | Times Cited: 37

Effects of the NF-κB Signaling Pathway Inhibitor BAY11-7082 in the Replication of ASFV
Qi Gao, Yunlong Yang, Yongzhi Feng, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 297-297
Open Access | Times Cited: 32

Accelerated immune ageing is associated with COVID-19 disease severity
Janet M. Lord, Tonny Veenith, Jack Sullivan, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7

Emerging Pro-neurogenic Therapeutic Strategies for Neurodegenerative Diseases: A Review of Pre-clinical and Clinical Research
Mariana Vassal, Filipa Martins, Bruno Monteiro, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 7

Metformin: A Possible Option in Cancer Chemotherapy
Chidiebere V. Ugwueze, Odunze J. Ogamba, Ekenechukwu Young, et al.
Analytical Cellular Pathology (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 48

Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
Marie Docherty, David Baird, Jeremy Hughes, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 46

Page 1 - Next Page

Scroll to top